Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MDMA-supported intensive experiential psychotherapy versus intensive body-focused integrative therapy for male Israeli veterans with military PTSD
MOH_2023-07-02_012787Phase 3Recruiting
- Sponsor
- Metiv - The Israel Psychotrauma Center
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of midomafetamine in post-traumatic stress disorder (PTSD) (2 arms), sponsored by Metiv - The Israel Psychotrauma Center. Started Jun 2023; status: recruiting.
02
Drugs
midomafetamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on MOH_2023-07-02_012787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2023-07-02_012787.